Reducing Complexity in Lipid Nanoparticles: Three-Component Zwitterionic Amino Lipids for Targeted Extrahepatic mRNA Delivery

Joshua Robinson(The University of Texas Southwestern Medical Center), Di Zhang(The University of Texas Southwestern Medical Center), Pratima Basak(The University of Texas Southwestern Medical Center), Amogh Vaidya(The University of Texas Southwestern Medical Center), Sumanta Chatterjee(The University of Texas Southwestern Medical Center), Xiaoyan Bian(The University of Texas Southwestern Medical Center), Minjung Kim(The University of Texas Southwestern Medical Center), Xizhen Lian(The University of Texas Southwestern Medical Center), Yehui Sun(The University of Texas Southwestern Medical Center), Erick Guerrero(The University of Texas Southwestern Medical Center), Xu Wang(The University of Texas Southwestern Medical Center), Sang M. Lee(The University of Texas Southwestern Medical Center), Shuai Liu(The University of Texas Southwestern Medical Center), Junyu Gong(The University of Texas Southwestern Medical Center), Mayank Tiwari(The University of Texas at Dallas), Godwin K. Babanyinah(The University of Texas at Dallas), Mihaela C. Stefan(The University of Texas at Dallas), Lukas Farbiak(The University of Texas Southwestern Medical Center), Daniel J. Siegwart(The University of Texas Southwestern Medical Center)
ACS Biomaterials Science & Engineering
July 9, 2025
10.1021/acsbiomaterials.5c00631
Cited by 2Open Access
Full Text

Abstract

Simplicity and chemical expansion of lipid nanoparticles (LNPs) offer the potential for increased therapeutic benefit of mRNA vaccines and medicines. 3-Component Zwitterionic Amino Lipid (ZAL) LNPs offer simplicity and varied organ target scope, though there is a lack of chemical and formulation exploration with this class of lipids. Herein, we report the synthesis and evaluation of ZALs with improved biocompatibility, enhanced mRNA delivery efficacy, and extrahepatic organ-specific delivery through derivation at the secondary hydroxyl position with opivalate, chloride, bromide, and acetate. Evaluation of these novel ZAL molecules revealed organ-specific delivery trends, changes in delivery efficacy, and an engineering framework for chemically modifying lipid components that correlate with each specific chemical modification. Furthermore, the most efficacious ZAL derivative, which contains an acetate modification, displayed enhanced immune cell transfection in an organ-specific manner. This study provides a roadmap for reducing the complexity of LNPs by decreasing the number of lipid components in an LNP from the canonical 4 lipids to 3 lipids and expands the chemical scope of LNPs capable of mediating extrahepatic delivery.

Related Papers

No related papers found

Powered by citation graph analysis